Claris Bio

Scroll
Investment area
Novo Ventures
Region
Western USA
Date of investment
June 2019

Claris Bio is a privately-held company developing a topical formulation of recombinant hepatocyte growth factor (rHGF) for the treatment of corneal wound / ulcers and scars.